The largest NLRB union election win in February was at the primary care group Optum Care, a subsidiary of UnitedHealthcare.

Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...

filed a lawsuit last month against OptumRx, a subsidiary of UnitedHealth Group, and Walgreens. In the lawsuit complaint, Cole's parents, Bil and Shanon Schmidtknecht, allege both OptumRx and ...

These changes are part of ongoing efforts to reduce total UnitedHealthcare prior authorization volume," the company said.

The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.

UnitedHealth Group faced two new investigations from federal lawmakers. The first was a senator’s probe into its Medicare ...

Lawmakers continue to push for healthcare reform, with some advocating for the breakup of large pharmacy benefit managers (PBMs) like UnitedHealth’s OptumRx, which negotiate drug prices on ...

Vertex Pharmaceuticals’ (VRTX) non-opioid pain drug Journavx was picked up by UnitedHealth’s (UNH) Optum on “Tier 3.” The insurer said, ...

is a diversified healthcare company that operates through UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx segments. The one-month return of UnitedHealth Group Incorporated (NYSE ...